Ingevity CorporationNGVTNYSE
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank23
Studio
Year-over-Year Change

Year-over-year SG&A expense growth

Percentile
P23
Within normal range
vs 5Y Ago
-0.3x
Contraction
Streak
3 qtr
Consecutive declineDecelerating
PeriodValue
Q4 2025-5.67%
Q3 2025-0.23%
Q2 20252.55%
Q1 20259.39%
Q4 20241.81%
Q3 2024-6.52%
Q2 2024-12.29%
Q1 20248.76%
Q4 20238.50%
Q3 2023-2.91%
Q2 2023-15.23%
Q1 2023-12.27%
Q4 202219.65%
Q3 2022-4.93%
Q2 202252.66%
Q1 2022-20.65%
Q4 2021-7.59%
Q3 2021-8.42%
Q2 202118.75%
Q1 2021-3.61%
Q4 202018.91%
Q3 20201.16%
Q2 2020-10.39%
Q1 2020-5.64%
Q4 20190.25%
Q3 2019-4.24%
Q2 20198.70%
Q1 20198.91%
Q4 20184.06%
Q3 2018-3.90%
Q2 201835.47%
Q1 2018-5.02%
Q4 20176.49%
Q3 2017-0.38%
Q2 20171.15%
Q1 2017-13.33%
Q4 20161.01%
Q3 20162.77%
Q2 20164.71%
Q1 20166.15%